Positive signal
2024 stands apart
It is the first filed year showing both the highest sales and a profit without financing income in the income statement.
Filed accountsFiled numbers, not market-size rhetoric
Atlas’s filings show real commercial activity and a materially better 2024. They also show an early company that relied on financing income in 2022–2023, has substantial receivables, and discloses no customers, product mix or export volume.
All amounts are BGN thousands and refer to Atlas Agro Science as a company, not to an individual product or distributor channel.
| Year | Net sales | Financing income | Total income | Expenses | After-tax result | Assets | Equity |
|---|---|---|---|---|---|---|---|
| 2021 | 6 | 0 | 6 | 7 | −1 | 54 | 11 |
| 2022 | 64 | 46 | 110 | 46 | 58 | 73 | 69 |
| 2023 | 149 | 123 | 272 | 296 | −24 | 63 | 45 |
| 2024 | 247 | 0 | 247 | 163 | 76 | 165 | 121 |
Positive signal
It is the first filed year showing both the highest sales and a profit without financing income in the income statement.
Filed accountsQuality of earnings
Financing supplied 42% of 2022 total income. In 2023 it supplied 45%, yet the company still recorded a loss.
Filed accountsWorking capital
2024 receivables were BGN 126k—about 51% of annual sales—against BGN 24k cash.
Balance sheetThe public record supports a mix of founder support, innovation-program awards, grant activity and trading revenue. It does not provide a complete funding ledger.
In August 2023 the company said it was not self-sustaining and that founders’ other businesses kept it operating. This is a direct point-in-time admission, not a current balance-sheet conclusion.
Atlas won the 2020 Bulgarian national prize and audience award, with published amounts of EUR 5,000 and EUR 2,000. It reached—but did not win—the international Grand Final.
The company’s beneficiary disclosure states a EUR 92,661 project budget and EUR 78,700 grant for testing, user preparation, marketing, management, audit and publicity from August 2022 through October 2023.
BGN 46k in 2022 and BGN 123k in 2023; none in the 2024 income statement. Deferred financing of BGN 17k remained on the 2024 balance sheet.
Atlas presents ATC Agro Finance as its exclusive sales channel and “part of the structure.” Registry records do not show it as an Atlas subsidiary.
What is public
Founded May 2021. Manager: Ivaylo Petrov Minkov. Owners: All Tax Consulting 60% and Ivaylo Petrov Minkov 40%.
Separate entity
What is not public
The exclusivity agreement, transfer pricing, commissions, inventory ownership, receivables split and any related-party economics were not found.
Contract needed
Shared surnames may suggest personal connections. This dossier does not infer family relationships without authoritative evidence.
A separate market-entry assessment tests a prospective German distribution business against legal routes, real competitors, farm economics and channel margins.
Category correction
The present product orders list molasses and leonardite. The direct comparison is the biostimulant market, not bulk sewage sludge.
Orders checkedTerritory
Public research found no German or Holland-based appointee, but private contracts and reservations cannot be excluded.
Authority requiredFarmer price
Modelled Terra treatment cost of €11–€33/ha sits inside the observed German biostimulant range.
ScenarioDistributor margin
At the visible 1,000+ L prices, direct gross margin is only about 10–16% under the base model and dealer sales lose money.
RenegotiateRecommended structure: Germany-only conditional exclusivity, no standalone rights fee, small original-pack pilot, and source-price targets near €5.30/L Terra, €6.40/L Nitro and €6.90/L Amino under the stated model.
Read the complete Germany market-entry and unit-economics assessment →
ATC advertised product plus agronomic support, analysis, drone application, financing and insurance-style services. Published availability is a webpage state, not proof of factory shutdown.
| Product | 5 L retail VAT included | 20 L tier per L, ex VAT | 1,000+ L tier per L, ex VAT | Direct page status |
|---|---|---|---|---|
| Atlas Terra | EUR 72.90 | EUR 10.74 | EUR 8.69 | Out of stock |
| Atlas Terra Nitro | EUR 82.20 | EUR 12.27 | EUR 10.23 | Out of stock |
| Atlas Terra Amino | EUR 91.20 | EUR 13.80 | EUR 11.76 | Out of stock |
Observed 30 August 2026. “Out of stock” could reflect inventory, ecommerce administration or channel strategy. Public evidence does not resolve which.
Atlas’s strategy targets 10% of a domestic market but does not define the denominator or date. A broad official expenditure category illustrates the distance between aspiration and current scale.
Do not quote the 0.026% as Atlas’s actual market share. The denominator includes categories and suppliers outside the company’s disclosed target. The calculation only makes the strategy’s undefined “10%” concrete enough to interrogate.
Public visibility is evidence of activity. It is not automatically evidence of contracted revenue or repeat demand.
The Atlas-issued “Green Certificate” is a marketing recognition, not a regulator or independent environmental certification. Recipient municipal pages confirm some relationships; at least some product was explicitly donated, so revenue cannot be inferred.